Please see the attached Good Practice for Advice & Guidance v1.4 and Advice & Guidance Update (Oct 2020) which includes a summary of the local progress, the feedback users have given via the survey, and the actions that are underway to keep evolving A&G.
If, following initial Advice and Guidance, the GP wishes to continue the conversation in eRS please see the attached process.
Secondary care teams are asking colleagues to be judicious in the use of advice and guidance during the crisis. The referral team suggest using the following 5 scenarios as appropriate criteria when seeking support in managing patients:
It is also suggested that referrers include a contact number eg. practice professional line or mobile telephone number when requesting A and G so that clinicians can contact them directly, if needed, to discuss a patient's care.
To enable the consultants to give the best advice possible please also consider the following points:
Advice and Guidance – operational delivery framework for ICBs for 25/26
A new framework is now available to support ICBs in delivering high-quality Advice and Guidance services. It aims to ensure consistent service improvement, innovation, and reduce unwarranted variation by setting out a roadmap for service maturity across seven domains.
This framework supports the planning, commissioning, and delivery of services in line with the Elective Reform plan. It will enhance the quality and consistency of Advice and Guidance services, ensuring timely, high-quality patient care.
The BNSSG Advice and Guidance Task and Finish group will be meeting regularly to agree how this will be implemented locally. The group includes representatives from the acute trusts, ICB and GPs (GPCB).
Efforts are made to ensure the accuracy and agreement of these guidelines, including any content uploaded, referred to or linked to from the system. However, BNSSG ICB cannot guarantee this. This guidance does not override the individual responsibility of healthcare professionals to make decisions appropriate to the circumstances of the individual patient, in consultation with the patient and/or guardian or carer, in accordance with the mental capacity act, and informed by the summary of product characteristics of any drugs they are considering. Practitioners are required to perform their duties in accordance with the law and their regulators and nothing in this guidance should be interpreted in a way that would be inconsistent with compliance with those duties.
Information provided through Remedy is continually updated so please be aware any printed copies may quickly become out of date.